Association of markers of systemic and local inflammation with prognosis of patients with rectal cancer who received neoadjuvant radiotherapy

References

• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• WiltinkLMNoutRAFioccoMNo increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 trialsJ Clin Oncol201533151640164625534376
   PubMed Web of Science ®Google Scholar
• YasuiMHasegawaYKawaharaTBaseline neutrophil-to-lymphocyte ratio predicts the prognosis of castration-resistant prostate cancer treated with abiraterone acetateMol Clin Oncol20188459259429541468
   PubMed Web of Science ®Google Scholar
• OjerholmESmithAHwangWTNeutrophil-to-lymphocyte ratio as a bladder cancer biomarker: assessing prognostic and predictive value in SWOG 8710Cancer2017123579480127787873
   PubMed Web of Science ®Google Scholar
• Semeniuk-WojtaśALubasAStecRSyryłoTNiemczykSSzczylikCNeutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: a systemic review and meta-analysisClin Genitourin Cancer2018163e685e69329454639
   PubMed Web of Science ®Google Scholar
• SeahJALeibowitz-AmitRAtenafuEGNeutrophil-lymphocyte ratio and pathological response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancerClin Genitourin Cancer2015134e229e23325777682
   PubMed Web of Science ®Google Scholar
• HuBFriedmanGElinavEFlavellRATransmissible inflammation-induced colorectal cancer in inflammasome-deficient miceOncoimmunology2018e981995
   Google Scholar
• FelicianoEMCKroenkeCHMeyerhardtJAAssociation of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS studyJAMA Oncol2017312e17231928796857
   PubMed Web of Science ®Google Scholar
• TempletonAJMcNamaraMGŠerugaBPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisJ Natl Cancer Inst20141066dju12424875653
   PubMedGoogle Scholar
• ChuaWCharlesKABaracosVEClarkeSJNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerBr J Cancer201110481288129521448173
   PubMed Web of Science ®Google Scholar
• HorneZDJackRGrayZTIncreased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancerJ Surg Res201117111521571304
   PubMed Web of Science ®Google Scholar
• KilicALandreneauRJLuketichJDPennathurASchuchertMJDensity of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumorsJ Surg Res2011167220721019896677
   PubMed Web of Science ®Google Scholar
• OshikiriTMiyamotoMShichinoheTPrognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune responseJ Surg Oncol200384422422814756433
   PubMed Web of Science ®Google Scholar
• NaitoYSaitoKShiibaKCD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancerCancer Res19985816349134949721846
   PubMed Web of Science ®Google Scholar
• HeoJOhYTNohOKChunMParkJEChoSRNodal tumor response according to the count of peripheral blood lymphocyte sub-populations during preoperative chemoradiotherapy in locally advanced rectal cancerRadiat Oncol J201634430531227927012
   PubMedGoogle Scholar
• KitayamaJYasudaKKawaiKSunamiENagawaHCirculating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancerRadiat Oncol2010514720525293
   PubMed Web of Science ®Google Scholar
• FangPJiangWDavuluriRHigh lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancerRadiother Oncol2018128358459029530432
   PubMed Web of Science ®Google Scholar
• LeeHJSeoJYAhnJHAhnSHGongGTumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patientsJ Breast Cancer2013161323923593079
   PubMed Web of Science ®Google Scholar
• DenkertCvon MinckwitzGBraseJCTumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancersJ Clin Oncol201533998399125534375
   PubMed Web of Science ®Google Scholar
• MandardAMDalibardFMandardJCPathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer19947311268026868194005
   PubMed Web of Science ®Google Scholar
• BudcziesJKlauschenFSinnBVCutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimizationPLoS One2012712e5186223251644
   PubMed Web of Science ®Google Scholar
• DengQHeBLiuXPrognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelJ Transl Med20151316625885254
   PubMedGoogle Scholar
• KimSTJeongHWooOHTumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancerAm J Clin Oncol201336322423122495453
   PubMed Web of Science ®Google Scholar
• LiXDaiDChenBTangHXieXWeiWThe value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: a systematic review and meta-analysisJ Cancer20189586187129581764
   PubMed Web of Science ®Google Scholar
• AsanoYKashiwagiSOnodaNPredictive value of neutrophil/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancerAnn Surg Oncol20162341104111026511266
   PubMed Web of Science ®Google Scholar
• MatsutaniSShibutaniMMaedaKSignificance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancerCancer Sci2018109496697929464828
   PubMed Web of Science ®Google Scholar
• XiaoBPengJZhangRDensity of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancerCancer Manag Res2017970170829225479
   PubMed Web of Science ®Google Scholar
• KalbasiAJuneCHHaasNVapiwalaNRadiation and immunotherapy: a synergistic combinationJ Clin Invest201312372756276323863633
   PubMed Web of Science ®Google Scholar
• TengFMuDMengXTumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancerAm J Cancer Res2015562064207426269765
   PubMed Web of Science ®Google Scholar
• BrandauSDumitruCALangSProtumor and antitumor functions of neutrophil granulocytesSemin Immunopathol201335216317623007469
   PubMed Web of Science ®Google Scholar
• FilatenkovABakerJMuellerAMAblative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissionsClin Cancer Res201521163727373925869387
   PubMed Web of Science ®Google Scholar
• KlebanoffCAGattinoniLRestifoNPCD8+ T-cell memory in tumor immunology and immunotherapyImmunol Rev2006211121422416824130
   PubMedGoogle Scholar